Skip to content
ST
Company

Updated:

SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001773427, and its reported...

Overview

SpringWorks Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001773427, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2025-02-20, it reported annual revenue of USD 191,589,000; net income of USD -258,131,000; total assets of USD 587,276,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
SpringWorks Therapeutics, Inc.
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
Stamford, CT, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001773427

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2024USD$191.6M-$258.1M$587.3M$69.8M-$175.6M
FY2023USD$5.4M-$325.1M$725.8M$176.1M-$222.8M
FY2022USD$0-$277.4M$630.2M$67.5M-$161.6M
FY2021USD$0-$173.9M$452.5M$104.0M-$127.9M

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
10-Q10-Q
8-KFORM 8-K
DEF 14ADEF 14A
10-K10-K
8-K8-K
8-KFORM 8-K
8-KFORM 8-K
10-Q10-Q

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research SpringWorks Therapeutics, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles